Publications by authors named "G Lopez Galmiche"

A growing body of evidence supports a role for tissue-to-diet N and C discrimination factors (ΔN and ΔC), as biomarkers of metabolic adaptations to nutritional stress, but the underlying mechanisms remain poorly understood. In obese rats fed ad libitum or subjected to gradual caloric restriction (CR), under a maintained protein intake, we measured ΔN and ΔC levels in tissue proteins and their constitutive amino acids (AA) and the expression of enzymes involved in the AA metabolism. CR was found to lower protein mass in the intestine, liver, heart and, to a lesser extent, some skeletal muscles.

View Article and Find Full Text PDF
Article Synopsis
  • In obese subjects, energy restriction often leads to a loss of both fat and muscle mass, but n-3 polyunsaturated fatty acids (PUFA) may help preserve muscle during weight loss.
  • Rats were fed a high-fat diet supplemented with different types of n-3 fatty acids before undergoing energy restriction; results showed significant differences in muscle loss depending on the type of n-3 fatty acid consumed.
  • The study suggests that n-3 PUFA improve insulin signaling pathways, helping to prevent muscle loss during energy restriction by enriching cell membranes with beneficial fatty acids.
View Article and Find Full Text PDF

Mineralocorticoid receptor (MR) antagonists slow down the progression of heart failure after myocardial infarction (MI), but the cell-specific role of MR in these benefits is unclear. In this study, the role of MR expressed in vascular smooth muscle cells (VSMCs) was investigated. Two months after coronary artery ligation causing MI, mice with VSMC-specific MR deletion (MI-MR(SMKO)) and mice treated with the MR antagonist finerenone (MI-fine) had improved left ventricular compliance and elastance when compared with infarcted control mice (MI-CTL), as well as reduced interstitial fibrosis.

View Article and Find Full Text PDF

Identification of the mineralocorticoid receptor (MR) in the vasculature (i.e., endothelial and smooth muscle cells) raised the question of its role in vascular function and blood pressure control.

View Article and Find Full Text PDF

Arterial stiffness is recognized as a risk factor for many cardiovascular diseases. Aldosterone via its binding to and activation of the mineralocorticoid receptors (MRs) is a main regulator of blood pressure by controlling renal sodium reabsorption. Although both clinical and experimental data indicate that MR activation by aldosterone is involved in arterial stiffening, the molecular mechanism is not known.

View Article and Find Full Text PDF